Lockey TD - Search Results

1

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Brown SA, Surman SL, Sealy R, Jones BG, Slobod KS, Branum K, Lockey TD, Howlett N, Freiden P, Flynn P, Hurwitz JL. Brown SA, et al. Among authors: lockey td. Viruses. 2010 Feb 1;2(2):435-467. doi: 10.3390/v2020435. Viruses. 2010. PMID: 20407589 Free PMC article.

2

Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?

Rencher SD, Slobod KS, Dawson DH, Lockey TD, Hurwitz JL. Rencher SD, et al. Among authors: lockey td. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1131-3. doi: 10.1089/aid.1995.11.1131. AIDS Res Hum Retroviruses. 1995. PMID: 8554911 No abstract available.

3

Eliminating graft-versus-host potential from T cell immunotherapeutic populations.

Rencher SD, Houston JA, Lockey TD, Hurwitz JL. Rencher SD, et al. Among authors: lockey td. Bone Marrow Transplant. 1996 Aug;18(2):415-20. Bone Marrow Transplant. 1996. PMID: 8864455

4

Fluctuating diversity in the HTLV-IIIB virus stock: implications for neutralization and challenge experiments.

Lockey TD, Slobod KS, Rencher SD, Srinivas RV, Hurwitz JL. Lockey TD, et al. AIDS Res Hum Retroviruses. 1996 Sep 1;12(13):1297-9. doi: 10.1089/aid.1996.12.1297. AIDS Res Hum Retroviruses. 1996. PMID: 8870852 No abstract available.

5

Drift from the GPGRAF HIV-1 envelope V3 crown sequence in a North American inner city.

Rencher SD, Lockey TD, Slobod KS, Hurwitz JL. Rencher SD, et al. Among authors: lockey td. AIDS Res Hum Retroviruses. 1997 Apr 10;13(6):527-8. doi: 10.1089/aid.1997.13.527. AIDS Res Hum Retroviruses. 1997. PMID: 9100996 No abstract available.

6

Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants.

Rencher SD, Lockey TD, Srinivas RV, Owens RJ, Hurwitz JL. Rencher SD, et al. Among authors: lockey td. Vaccine. 1997 Feb;15(3):265-72. doi: 10.1016/s0264-410x(96)00185-5. Vaccine. 1997. PMID: 9139484

7

Size-heterogeneous sequences mark hot spots for asparagine, serine, and threonine insertions in HIV type 1 envelope.

Lockey TD, Hurwitz JL. Lockey TD, et al. AIDS Res Hum Retroviruses. 1998 May 20;14(8):717-9. doi: 10.1089/aid.1998.14.717. AIDS Res Hum Retroviruses. 1998. PMID: 9618085 No abstract available.

8

A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation.

Caver TE, Lockey TD, Srinivas RV, Webster RG, Hurwitz JL. Caver TE, et al. Among authors: lockey td. Vaccine. 1999 Mar 17;17(11-12):1567-72. doi: 10.1016/s0264-410x(98)00355-7. Vaccine. 1999. PMID: 10195794

9

Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.

Lockey TD, Slobod KS, Caver TE, D'Costa S, Owens RJ, McClure HM, Compans RW, Hurwitz JL. Lockey TD, et al. Immunol Res. 2000;21(1):7-21. doi: 10.1385/IR:21:1:7. Immunol Res. 2000. PMID: 10803879

10

Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.

Surman S, Lockey TD, Slobod KS, Jones B, Riberdy JM, White SW, Doherty PC, Hurwitz JL. Surman S, et al. Among authors: lockey td. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4587-92. doi: 10.1073/pnas.071063898. Epub 2001 Apr 3. Proc Natl Acad Sci U S A. 2001. PMID: 11287644 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters